Sandoz Group AG | Finanzwire

Basculer en Français

10465	Companies
220097	Keywords
149424	Articles
116368	Press releases

Home
Companies
Sandoz Group AG

BRIEF

published on 02/23/2026 at 11:05, 3 months 4 days ago

Sandoz Gains EU Approval for Ranluspec, Enhancing Biosimilars Position

European Commission Biosimilars Ophthalmology Sandoz Strategy Ranluspec Approval
PRESS RELEASE

published on 02/23/2026 at 11:00, 3 months 4 days ago

Sandoz confirms European Commission approval for Ranluspec® (ranibizumab), further strengthening overall biosimilars leadership and position in ophthalmology
Sandoz confirms European Commission approval for Ranluspec®, strengthening biosimilars leadership in ophthalmology. Launch planned for second half of 2026

Biosimilars Ophthalmology Sandoz European Commission Approval Ranluspec
BRIEF

published on 02/18/2026 at 07:05, 3 months 10 days ago

Sandoz Expands Enzeevu® Label with FDA Approval for Retinal Indications

FDA Approval Biosimilars Sandoz Enzeevu Retinal Indications
PRESS RELEASE

published on 02/18/2026 at 07:00, 3 months 10 days ago

Sandoz receives US FDA approval to expand Enzeevu® (aflibercept-abzv) label for multiple retinal indications
Sandoz receives US FDA approval to expand Enzeevu® (aflibercept-abzv) label to include multiple retinal indications, offering new treatment options for retinal diseases

FDA Approval Vision Care Sandoz Enzeevu Retinal Indications
BRIEF

published on 01/14/2026 at 12:05, 4 months 13 days ago

Sandoz Secures EU Approval for Ondibta® in Diabetes Treatment

European Commission Biosimilars Diabetes Treatment Ondibta® Approval Sandoz Strategy
PRESS RELEASE

published on 01/14/2026 at 12:00, 4 months 13 days ago

Sandoz confirms European Commission approval of Ondibta® (insulin glargine), strengthening overall biosimilars leadership and position in diabetes
Sandoz confirms European Commission approval of Ondibta® (insulin glargine), strengthening overall biosimilars leadership and position in diabetes. Expected launch by early 2027

Diabetes European Commission Biosimilars Sandoz Ondibta
BRIEF

published on 01/12/2026 at 15:05, 4 months 15 days ago

Sandoz Unveils Strategy for 'Golden Decade' of Affordable Medicines

Market Strategy Biosimilars Sandoz Group AG Golden Decade Affordable Medicines
PRESS RELEASE

published on 01/12/2026 at 15:00, 4 months 15 days ago

Sandoz CEO, speaking at 44th Annual J.P. Morgan Healthcare Conference, will outline plans to capitalize on unprecedented ’golden decade’ of affordable medicines opportunity
Sandoz CEO to outline plans for capturing the unprecedented 'golden decade' of affordable medicines opportunity at the 44th Annual J.P. Morgan Healthcare Conference

CEO Sandoz J.P. Morgan Healthcare Conference Golden Decade Affordable Medicines
BRIEF

published on 12/08/2025 at 07:05, 5 months 20 days ago

Sandoz Acquires Just-Evotec Biologics EU SAS to Boost Biosimilar Leadership

Acquisition Healthcare Biosimilars Sandoz Group AG Continuous Manufacturing
PRESS RELEASE

published on 12/08/2025 at 07:00, 5 months 20 days ago

Sandoz completes strategic acquisition of Just-Evotec Biologics EU SAS, asserting biosimilars leadership
Sandoz completes strategic acquisition of Just-Evotec Biologics EU SAS, asserting biosimilars leadership. Expands capabilities for biosimilars with cutting-edge technology

Acquisition Biosimilars Sandoz Just-Evotec Biologics EU SAS Continuous-manufacturing Technology

Accesswire

Published on 05/28/2026 at 10:10, 12 minutes ago

Powering Macau's Smart Future with AI - MACAU Pass and Ant Bank (Macao) Partner with Alibaba Ecosystem to Showcase Smart City Vision at BEYOND Expo
Published on 05/28/2026 at 09:05, 1 hour 17 minutes ago

Tocvan Intersects Three New Gold-Silver Zones at Gran Pilar Project Exploration Drilling; Provides Pilot Mine Development Update
Published on 05/28/2026 at 09:01, 1 hour 21 minutes ago

Discovery Energy Metals Corp. Mobilizes Crews for Surface Sampling Program at Crystal Lake Cu-Mo Project, British Columbia
Published on 05/28/2026 at 09:00, 1 hour 22 minutes ago

Applications are Open for the 2026 Semmelweis-Richter Journalism Award Until June 9th
Published on 05/28/2026 at 08:00, 2 hours 22 minutes ago

Touchstone Exploration Provides An Operational Update

View all ACCESSWIRE

EQS Group

Published on 05/28/2026 at 10:10, 11 minutes ago

SMT Scharf AG is successfully pursuing its strategy in the field of electric mobility
Published on 05/28/2026 at 10:10, 11 minutes ago

Huawei Named a Leader in the 2026 Gartner® Magic Quadrant™ for Enterprise Wired and Wireless LAN Infrastructure for the Fourth Year in a Row
Published on 05/28/2026 at 10:00, 21 minutes ago

REPLOID receives supply order from German circular economy company “PreZero Stiftung & Co. KG”; discussions underway on deepening collaboration
Published on 05/28/2026 at 09:45, 36 minutes ago

Powering Macau's Smart Future with AI —MACAU Pass and Ant Bank (Macao) Partner with Alibaba Ecosystem to Showcase Smart City Vision at BEYOND Expo
Published on 05/28/2026 at 09:30, 51 minutes ago

Topadur Pharma AG Adds Senior Board Expertise with Appointment of Dr. Felix R. Ehrat and Dr. Peter Jager

Les Echos

Published on 05/28/2026 at 08:45, 1 hour 37 minutes ago

Appointment of Mikael Frenkian as Chief Executive Officer of Baikowski
Published on 05/27/2026 at 23:00, 11 hours 22 minutes ago

BIOPHYTIS CHANGES ITS FINANCING AGREEMENT WITH HEXAGON CAPITAL FUND TO ENSURE ITS €2 MILLION FACILITY IS RENEWABLE
Published on 05/27/2026 at 20:28, 13 hours 53 minutes ago

Combined Shareholders’ Meeting of May 27, 2026
Published on 05/27/2026 at 17:45, 16 hours 37 minutes ago

Imerys-05-2026-information-share-capital-and-voting-rights-as-of-30-April-2026
Published on 05/27/2026 at 17:45, 16 hours 37 minutes ago

Description of Share buyback program - May 2026

View all LES ECHOS COMFI WIRE